VERA - Total Utang marang Modal Vera Corp
Vera Therapeutics, Inc. (VERA) is implementing ESG principles by minimizing laboratory waste during the development of immune drugs. The company's leverage history reflects its borrowing dynamics, with the current value standing at 0.18. Nephrologists highly value Vera Therapeutics, Inc. (VERA) for its innovations in kidney treatment, while its market positions are protected by complex patents and high FDA certification costs.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_VERA_-_Vera-Therapeutics-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "VERA (Vera Therapeutics, Inc.) riwayat Total Utang marang Modal saka 04.07.2022 nganti 01.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Vera Therapeutics, Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Vera Therapeutics, Inc.|VERA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Vera Therapeutics, Inc.|VERA - Gunggung utang perusahaan|Utang marang nilai buku Vera Therapeutics|VERA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Vera Therapeutics|Likuiditas cepet veratx.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Vera Therapeutics
This ratio determines the share of borrowed capital within the overall asset financing structure. Investors utilize it to assess financial stability and the extent of the business's dependence on creditors. By analyzing the liability structure—total debt to equity—one can determine bankruptcy risk or growth potential. For Vera Therapeutics, Inc. (VERA), low leverage confirms the efficiency of production outsourcing. The absence of capital expenditures minimizes the need for debt financing.
Analisis pesaing Vera Therapeutics, Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ABCL (abcellera.com)|Koefisien Total Utang marang Modal Tourmaline (TRML)|PGEN - Utang marang Ekuitas|pharming.com (PHAR) - Rasio Total Utang marang Ekuitas|Nektar Therapeutics Inc. (NKTR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Upstream Bio, Inc.|Rasio Total Utang marang Ekuitas ZBIO|Total Utang marang Modal Immunome Bio|Utang marang Ekuitas Gossamer Bio, Inc. (GOSS)|kalvista.com - Rasio Utang marang Ekuitas|Total Utang marang Modal SEPN (Septerna)|Pieris Pharma (PVLA) - Utang marang Modal|SVRA: Rasio Total Utang marang Ekuitas|RIGL: Utang marang Ekuitas|ANAB: Total Utang marang Modal|Utang marang Modal astriatx.com (ATXS)|Utang marang Ekuitas enGene|RAPT: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal JBIO|Total Utang marang Modal Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TLSA|CABA: Rasio Total Utang marang Ekuitas|Ventyx Biosciences Inc. - Utang Agregat marang Modal|THTX: Total Utang marang Modal|Avalo Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|ELDN (Eledon Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal agenusbio.com AGEN|Utang marang Ekuitas Climb Bio (CLYM)|ZURA (Zura Bio Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ATYR (aTyr)|Total Utang marang Modal Adagene Inc ADAG|IMA - Utang marang Ekuitas|Utang Agregat marang Ekuitas STTK|EQ: Total Utang marang Modal|Utang marang Modal Connect Biopharma Holdings Limited (CNTB)|Rasio Total Utang marang Ekuitas IMUX|Total Utang marang Modal Atara Biotherapeutics Inc|Rasio Total Utang marang Ekuitas IFRX (InflaRx N.V.)|Utang Agregat marang Modal XFOR|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Koefisien Total Utang marang Modal Celularity Inc (CELU)|INmune Bio Corp - Total Utang marang Modal|Barinthus Biotherapeutics Corp (BRNS) - Rasio Total Utang marang Ekuitas|Kezar Life Sciences (KZR) - Utang marang Ekuitas|SABS - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas AKTX|ENLV: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal QTTB|Koefisien Total Utang marang Modal GeoVax Corp|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|IBIO: Rasio Utang marang Ekuitas|Carisma Tx - Total Utang marang Modal|XTL Biopharmaceuticals Ltd (XTLB) - Rasio Total Utang marang Ekuitas|BOLT (boltbio.com) - Rasio Total Utang marang Ekuitas|HCWB - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas APVO|Utang marang Ekuitas AIM|Total Utang marang Modal ADTX|GRI - Utang marang Modal|Utang marang Ekuitas XORTX XRTX|Rasio Kabeh Utang marang Dana Pribadi HIND|Revelation Biosciences - Total Utang marang Modal|INDP - Total Utang marang Modal|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas CALI (CalciMedica)|AFMD (Affimed NV) - Total Utang marang Modal|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|Rasio Kabeh Utang marang Dana Pribadi OCEA|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas